On Thursday, November 30, 2017 at 1:43:58 AM UTC-5, Dene wrote:
> Something wrong with 60% benefitting?
Yes, because of how "benefit" is defined. The metric being used is $100/year:
"More than 60 percent of households would see a tax cut of at least $100 in 2019".
The problem with that metric is that since the bill isn't revenue-neutral, it is
achieving some "savings" merely by knowingly adding to the National Debt.
There's 125.82 million households in the USA, so this "borrow and spend"
has a per-household magnitude of ~$1200/year per household.
TL;DR: the "benefit" needs to be defined as being more than $1200/yr to
actually be a savings, instead of an increased deficit "borrowing".
Plus even their claimed 'benefit' is transient:
"In 2027, after the tax cuts for individuals expire, ... only about 16 percent would
see tax cuts of at least $100."
Bottom line is that you're trying to brag about what will probably work out
to be not much more than $100/yr * 9 years = $900 savings ...
> What happens 10 years from now is irrelevant.
No, because while you're gloating over your $100/yr (for only 9 years) break,
all US households are also taking on an additional $12K/household in debt.
And from a debt service standpoint, even at an optimistic 4% interest rate,
the annual -- per household -- cost for that increase in National Debt grows
annually to be no less than $480/year by the end of this bill's proposed period.
TL;DR: a $100/yr "savings" results in interest payments that grow to $480/yr by 2029.
Still want to claim that this sort of fiscal policy is "America First"?
I don't. This bill is a total rape of the general American public, and by
knowingly using bad & deceptive metrics, its proponents know it too.
> BTW...hope lawmakers delete the individual mandate repeal.
Agreed -- but they still haven't yet done so.
BTW, attended a lecture yesterday, where one of the topics that was discussed
included drug costs. Some of the problems are systemic, such as how the
patent on a drug is for only 21 years, but it typically takes 16 years from
invention to get it through all testing and to market, so the payback window
is relatively short. What I found more interesting is that the first "FDA" style
drug safety laws --- circa 1902? -- create some conflict-of-interest elements,
so we've had this bad structure for a century.
-hh